Quick Answer
BIOGEN INC. reported Earnings Per Share Diluted of $8.79 per share for the year ending 2025.
- BIOGEN INC. showed a decrease of -21.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), BIOGEN INC.'s Earnings Per Share Diluted has grown by 231.7%.
- Historical annual values: Fiscal year 2025: $8.79 per share | Fiscal year 2024: $11.18 per share | Fiscal year 2023: $7.97 per share | Fiscal year 2022: $20.87 per share | Fiscal year 2021: $10.40 per share | Fiscal year 2020: $24.80 per share | Fiscal year 2019: $31.42 per share | Fiscal year 2018: $21.58 per share | Fiscal year 2017: $11.92 per share | Fiscal year 2016: $16.93 per share | Fiscal year 2015: $15.34 per share | Fiscal year 2014: $12.37 per share | Fiscal year 2013: $7.81 per share | Fiscal year 2012: $5.76 per share | Fiscal year 2011: $5.04 per share | Fiscal year 2010: $3.94 per share | Fiscal year 2009: $3.35 per share | Fiscal year 2008: $2.65 per share.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: